Simplifying Type 2 Diabetes Management with Once-Weekly Semaglutide and Basal Insulin
Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
Study Design
Population
The study population is not specified in the provided digest.
Intervention
Once-weekly semaglutide was administered.
Comparator
The comparator is not specified in the provided digest.
Outcome
The primary outcome measured is not specified in the provided digest.
Abstract
Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With Type-2 Diabetes Mellitus (TRANSITION-T2D) A Prospective Randomized Controlled Trial
NCT ID: NCT04538352
Status: COMPLETED
Sponsor: The C…